Estimated Cost of Treating the Uninsured Hospitalized with COVID-19
This brief estimates the total amount that will be spent to reimburse hospitals for care for the uninsured with COVID-19, the disease caused by the coronavirus.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This brief estimates the total amount that will be spent to reimburse hospitals for care for the uninsured with COVID-19, the disease caused by the coronavirus.
As the largest payer of substance use disorder services in the United States, Medicaid plays a central role in state efforts to address the opioid epidemic. In addition to increasing access to addiction treatment services through the expansion of Medicaid under the Affordable Care Act (ACA), states are expanding Medicaid addiction treatment services, increasing provider reimbursements, restricting opioid prescribing, and implementing delivery system reforms to improve the quality of treatment services. While many states have…
This data note describes uninsured nonelderly adults with opioid use disorder, including their demographic characteristics, health status, and access to treatment.
This brief describes nonelderly adults with opioid use disorder, including their demographic characteristics and insurance status, and compares utilization of treatment services among those with Medicaid to those with other types of coverage. It also describes Medicaid financing for opioid treatment and the ways in which Medicaid promotes access to treatment for enrollees with OUD.
During this year’s State of the Union address, President Trump announced a new effort “to eliminate the HIV epidemic in the United States within 10 years,” drawing national attention to the domestic epidemic and the promise of new prevention and treatment options that greatly reduce the risk of HIV transmission. The initiative includes a focus on 48 counties, seven states, Washington D.C. and San Juan, Puerto Rico – all places with high urban or rural…
On August 3, the Kaiser Family Foundation and the Center for Strategic and International Studies (CSIS) hosted a briefing to assess the major outcomes of the 2016 International AIDS Conference (AIDS 2016), held from July 18-22 in Durban, South Africa. The discussion touched on the latest scientific advancements, the current funding climate for HIV response, and other developments and contributions to the field emerging from the conference. Panelists included Chris Beyrer, Immediate Past President of the International AIDS Society;…
The Kaiser Family Foundation held an interactive web briefing on Tuesday, June 21 to discuss key issues to be addressed at the upcoming International AIDS Conference on July 18-22. The conference will convene in Durban, South Africa, 16 years after it was first held there. The world has seen dramatic progress in the fight against AIDS since 2000, but what key challenges remain in achieving the goal of an end to AIDS? What are the latest clinical,…
Americans and HIV-AIDS – Selected 2014 National Survey Findings from the Kaiser Family Foundation Download
This was published as a Wall Street Journal Think Tank column on Jul7 27, 2015. Many Americans are skeptical about foreign aid because they believe a large share of U.S. assistance is lost to corruption. When it comes to global health, as the chart above shows, 83% of Americans say corruption and misuse of funds is a barrier to improving health in developing nations, and 43% say it is the most important barrier. Corruption is a problem. World…
In his latest column for The Wall Street Journal's Think Tank, Drew Altman discusses a recent success in global HIV treatment and how successes may get less attention than they deserve because of prevailing attitudes about the corruption in foreign aid. All previous columns by Drew Altman are available.
© 2026 KFF